Network analysis confirmed that tumor suppressors (e.g., TP53, BRCA1) and oncogenes (e.g., EGFR, KRAS, MYC) were components of the network of parent proteins represented by the identified class I-presented peptides (supplemental Fig. S3E). This evidence concerns the gene EGFR and neoplasm.